The present study examined IMP3 expression and the clinicopathological features of NSCLC, and found that IMP3 expression was significantly correlated with a large tumor size, poor differentiation, positive node status and advanced clinical stage, but not with age, gender, pathological subtype, CEA level or smoking status of patients with NSCLC. This evidence concerns the gene IMP3 and non-small cell lung carcinoma.